Panc Support Project (PSP): Evaluating the integration of palliative care into a pancreatic cancer program at a comprehensive cancer center.

Authors

null

Eve Makoff

Cedars-Sinai Medical Center, Los Angeles, CA

Eve Makoff, Arvind Manohar Shinde, Richard Tuli, Andrew Eugene Hendifar

Organizations

Cedars-Sinai Medical Center, Los Angeles, CA, City of Hope, Arcadia, CA, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA

Research Funding

No funding sources reported

Background: Pancreatic adenocarcinoma is the 4th leading cause of cancer death in the US. It is predicted to become the 2nd leading cause by 2030. Advanced disease at diagnosis is common. Fewer than 20% of patients having long-term disease control. Given the high prevalence of physical and psychosocial needs, a quality initiative that embedded a PC physician in a pancreatic cancer program was initiated. Methods: From June 2015-October 2015, all stage III/IV pancreatic adenocarcinoma patients were referred for palliative consultation. * The PC physician was introduced as a supportive care medicine provider; a part of the comprehensive pancreas cancer program. *Other resources (ie RN, SW, Chaplain, RD) deployed as indicated *Patients seen initially and at least every 2 months * ESAS, PHQ2, and spiritual screens performed regularly * Data collected regarding symptom trajectory, resource utilization; and timing/place of death. Results: N=17. Conclusions: PSP demonstrated the ability of a PC provider to be effectively accepted and integrated into a pancreas program. Results suggest a benefit in the standardization of symptom screening/ intervention, and a possible favorable impact on healthcare resource utilization. Outcomes will continue to be tracked and compared with patients in the larger cancer community. Further study is indicated to assess the scalability and impact of this model of integrated care.

Patient results.

DataN (%)
Median age65
Sex
Male
Female
10 (58)
7 (42)
Avg. # of visits4
Status:
Expired4
Non-ICU inpt1
Hospice3
Hospice2
Surgery1
Imminent surgery1
On treatment9
% PHQ2/Spiritual screen completed76
% ESAS Completed82
Initial visit mod-severe symptoms (>/= 4 on ESAS)(%)
Appetite52
Fatigue47
Wellbeing/pain41
Sleep/depression/nausea29
Drowsy/sob23
Subsequent visit scores were < 4 (mild) for sleep, depression, nausea, drowsy and sob.
The following were 4-4.8 (mod):
Appetite50
Fatigue50
Wellbeing/pain50

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2016 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Science of Quality

Track

Cost, Value, and Policy in Quality,Practice of Quality,Science of Quality

Sub Track

Quality Improvement

Citation

J Clin Oncol 34, 2016 (suppl 7S; abstr 241)

DOI

10.1200/jco.2016.34.7_suppl.241

Abstract #

241

Poster Bd #

H2

Abstract Disclosures

Similar Abstracts

First Author: Anjali Goyal

Abstract

2023 ASCO Quality Care Symposium

Long-acting opioids as a trigger for palliative care consultation in pancreatic cancer.

First Author: Richa Thakur

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Early results of a pancreas cancer learning health network: Canopy Cancer Collective.

First Author: Joseph M. Herman